Published in
Taylor and Francis Group, Leukemia & Lymphoma, 6(62), p. 1361-1369, 2021
DOI: 10.1080/10428194.2020.1869965
Links
Tools
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Journal article published in 2021 by
Alexander Augustyn,
L. Jeffrey Medeiros,
Ethan B. Ludmir 
,
Jillian Gunther,
Penny Fang,
Shaoying Li,
Chi Young Ok,
Mikaela E. Bankston,
Vivek Verma,
Dario Pasalic ,
Sairah Ahmed,
Loretta J. Nastoupil,
Jason R. Westin ,
Paolo Strati ,
Sattva S. Neelapu
and other authors.
,
Jillian Gunther,
Penny Fang,
Shaoying Li,
Chi Young Ok,
Mikaela E. Bankston,
Vivek Verma,
Dario Pasalic ,
Sairah Ahmed,
Loretta J. Nastoupil,
Jason R. Westin ,
Paolo Strati ,
Sattva S. Neelapu
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 